Soriatane and Fenofibrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Soriatane (acitretin) and Fenofibrate (fenofibrate). Common drug interactions include microcytic anaemia among females and acute myocardial infarction among males.

The phase IV clinical study analyzes what interactions people have when they take Soriatane and Fenofibrate. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Soriatane?

Soriatane has active ingredients of acitretin. It is often used in psoriasis. eHealthMe is studying from 3,834 Soriatane users. Check the latest studies of Soriatane.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

On Jul, 22, 2026

21 people who take Soriatane and Fenofibrate together, and have interactions are studied.

Soriatane and Fenofibrate drug interactions.

What are the common drug interactions of Soriatane and Fenofibrate, by gender? *:

female:

Microcytic anaemia (a generic term for any type of anaemia characterized by small red blood cells)
General physical health deterioration (weak health status)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Back pain
Depression
Emotional distress
Foot fracture
Gait disturbance
Multiple fractures

male:

Acute myocardial infarction (acute heart attack)
Asthenia (weakness)
Epistaxis (bleed from the nose)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hypotension (abnormally low blood pressure)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Alanine aminotransferase increased
Arthralgia (joint pain)
Bacterial infection
Blood pressure decreased

What are the common drug interactions of Soriatane and Fenofibrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Acute myocardial infarction (acute heart attack)
Alanine aminotransferase increased
Asthenia (weakness)
Blood pressure decreased
Cachexia (loss of weight)
Candidiasis (candidiasis or thrush is a fungal infection)
Chest discomfort
Chest pain
Clostridium test positive
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)

20-29:

n/a

30-39:

n/a

40-49:

Microcytic anaemia (a generic term for any type of anaemia characterized by small red blood cells)
General physical health deterioration (weak health status)
Blood alkaline phosphatase increased
Drug ineffective
Coronary artery stenosis (narrowing of coronary artery)
Diarrhoea infectious (bacteria, viruses, and other germs can cause diarrhoea)
Epistaxis (bleed from the nose)
Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
Hypokinesia (decreased bodily movement)
Hypotension (abnormally low blood pressure)

50-59:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Back pain
Depression
Emotional distress
Foot fracture
Gait disturbance
Multiple fractures
Osteoporosis (bones weak and more likely to break)
Pain

60+:

Acute myocardial infarction (acute heart attack)
Asthenia (weakness)
Vomiting
Bacterial infection
Brain injury
Constipation
Diarrhoea
Lip dry
Rhinorrhoea (watery mucus discharge from the nose)
Weight decreased

What are the existing conditions these people have? *

Oesophageal Carcinoma (cancer tumour of oesophagus): 3 people, 14.29%
Insomnia (sleeplessness): 3 people, 14.29%
Ichthyosis (genetic skin disorders): 3 people, 14.29%
Depression: 3 people, 14.29%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 9.52%
Skin Cancer: 2 people, 9.52%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 9.52%
Joint Pain: 2 people, 9.52%
Hiv Infection: 2 people, 9.52%
Heart Attack: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Soriatane and Fenofibrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously